Similar biological medicinal products containing recombinant erythropoietins

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/BMWP/301636/08
Effective from01/12/2012
KeywordsErythropoietin, epoetin, recombinant biological medicinal products, indication, efficacy, safety, comparability, extrapolation
DescriptionThis document lays down lays down the non-clinical and clinical requirements for recombinant human erythropoietin (epoetin)-containing medicinal products claiming to be similar to another one already marketed.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/12/2012–present

Published: 24/01/2011

Published: 23/07/2009

Published: 24/07/2008

Superseded document

Adopted guideline

Submission of comments

In operation: 01/07/2006–30/11/2012

Published: 01/03/2006

Related content

How helpful is this page?

Average rating:

 Based on 17 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
5 ratings

Tell us more